Nugenic Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.87 Cr
as on 15-11-2024
- Company Age 20 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.20 Cr
as on 15-11-2024
- Satisfied Charges ₹ 6.78 Cr
as on 15-11-2024
- Revenue 26.34%
(FY 2023)
- Profit 467.11%
(FY 2023)
- Ebitda 21.63%
(FY 2023)
- Net Worth 4.60%
(FY 2023)
- Total Assets -15.25%
(FY 2023)
About Nugenic Pharma
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.87 Cr.
The company currently has active open charges totaling ₹25.20 Cr. The company has closed loans amounting to ₹6.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Lohariwala, Rohit Lohariwala, Rahul Luhariwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230HP2004PTC027717
- Company No.
027717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nugenic Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Lohariwala  | Director | 09-Dec-2004 | Current |
| Rohit Lohariwala | Director | 20-Mar-2014 | Current |
| Rahul Luhariwala | Director | 21-Oct-2021 | Current |
| Vinay Lohariwala | Director | 09-Dec-2004 | Current |
Financial Performance and Corporate Structure Insights of Nugenic Pharma.
Nugenic Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial improvement in profitability, with a 467.11% increase in profit. The company's net worth moved up by a moderate rise of 4.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nugenic Pharma?
In 2023, Nugenic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Univentis Medicare LimitedActive 9 years 5 monthsManoj Lohariwala and Vinay Lohariwala are mutual person
Innova Captab LimitedActive 19 years 11 monthsManoj Lohariwala and Vinay Lohariwala are mutual person
Innoventis Medicare LimitedActive 4 years 6 monthsManoj Lohariwala, Rohit Lohariwala and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 05 Oct 2020 | ₹25.20 Cr | Open |
State Bank Of India Creation Date: 01 Nov 2011 | ₹4.58 Cr | Satisfied |
Axis Bank Ltd. Creation Date: 25 Feb 2011 | ₹2.20 Cr | Satisfied |
How Many Employees Work at Nugenic Pharma?
Nugenic Pharma has a workforce of 232 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nugenic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nugenic Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
